Literature DB >> 28400099

Quality of life and functional capacity in patients with rheumatoid arthritis - Cross-sectional study.

Diana Rosa-Gonçalves1, Miguel Bernardes2, Lúcia Costa2.   

Abstract

OBJECTIVES: To analyze the Health related Quality of Life (HRQoL) and physical function in rheumatoid arthritis (RA) patients and compare it with the general population. We also intended to analyze about disease activity influence in HRQoL and functional capacity, as well as determine potential determinants for these outcomes.
MATERIAL AND METHODS: A cross-sectional study was conducted in RA patients from a university hospital of Portugal. We obtained Short Form 36, EuroQoL 5D, health assessment questionnaire, visual analog scale for pain and patient's assessment of disease activity. Comparisons between SF-36 and EQ-5D values with our population reference values were conducted using the Mann-Whitney test. Data were compared in different levels of disease activity, using Kruskal Wallis test and Fisher's exact test. A multiple regression analysis was conducted to identify the potential determinants of outcomes.
RESULTS: RA sample showed significantly lower values than the portuguese general population on physical summary measure of SF-36 (median=32 vs. 50, p<0.001) and EQ-5D (median=0.620 vs. 0.758 respectively; p<0.001). Lower disease activity levels had better PROs and this was true even when compared patients achieving remission with those in low disease activity. The HAQ (r2=67%), VAS-P (r2=62%) and VAS-DA (r2=58%) were the variables that strongly related to SF-36. Considering HAQ, the strongest relation was found with VAS-P, VAS-DA and age (r2=60%, 61% and 33%, respectively). Multiple regression analysis identified HAQ, VAS-P and educational status as determinants of the HRQoL; age, female gender, employment, VAS-P and VAS-DA as determinants of physical function.
CONCLUSION: Impairment of HRQoL in RA patients is enormous. We found significant differences between different levels of disease activity, showing higher HRQoL and functional capacity at lower disease activity levels.
Copyright © 2017 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.

Entities:  

Keywords:  Artritis reumatoide; Capacidad funcional; Functional capacity; HAQ; Quality of life; Rheumatoid arthritis; SF-36

Mesh:

Substances:

Year:  2017        PMID: 28400099     DOI: 10.1016/j.reuma.2017.03.002

Source DB:  PubMed          Journal:  Reumatol Clin (Engl Ed)        ISSN: 2173-5743


  5 in total

1.  Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study.

Authors:  Francesco Salvatore Iaquinta; Rosa Daniela Grembiale; Daniele Mauro; Ilenia Pantano; Saverio Naty; Cristina Cosco; Daniela Iacono; Emanuela Gaggiano; Annarita Ruggiero; Francesco Ciccia; Patrizia Doldo; Rocco Spagnuolo
Journal:  J Clin Med       Date:  2022-04-27       Impact factor: 4.964

2.  Changes of DCE-MRI Parameters in Patients with Rheumatoid Arthritis before and after Therapy and Their Value for the Efficacy Evaluation of Patients.

Authors:  Danguo Chen; Shengquan He
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-18       Impact factor: 2.629

3.  Treatment of Rheumatoid Arthritis with Certolizumab Pegol: Results from PROACTIVE, a Non-Interventional Study in the UK and Ireland.

Authors:  Namita Kumar; Sophia Naz; Mark Quinn; John Ryan; Thomas Kumke; Tom Sheeran
Journal:  Adv Ther       Date:  2018-08-03       Impact factor: 3.845

4.  Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study.

Authors:  Mónica Inês; Teresa Coelho; Isabel Conceição; Lara Ferreira; Mamede de Carvalho; João Costa
Journal:  Orphanet J Rare Dis       Date:  2020-03-06       Impact factor: 4.123

Review 5.  Therapeutic Benefits of Balneotherapy on Quality of Life of Patients with Rheumatoid Arthritis: A Systematic Review.

Authors:  Maria Fernandez-Gonzalez; Carolina Fernandez-Lao; Lydia Martin-Martin; Angela Gonzalez-Santos; Maria Lopez-Garzon; Lucia Ortiz-Comino; Mario Lozano-Lozano
Journal:  Int J Environ Res Public Health       Date:  2021-12-15       Impact factor: 3.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.